When we restricted the analysis to patients with metastatic tumor (stage 4), high mRNA levels of CD55 showed a trend for the association with overall and relapse-free survival but not in the subset of patients with localized tumors (stage 1–2–3; Supplementary Figure 6). This evidence concerns the gene CD55 and metastatic neoplasm.